What is a ‘normal’ value for dawn phenomena for you for people with insulin resistance if you're on a GLP-1 like semaglutide or tirzepatide?

Understanding Dawn Phenomenon in Insulin Resistance

In my 30 years of clinical practice and through the 30-Week Tirzepatide Reset, I have found that the dawn phenomenon—the natural early-morning rise in blood glucose driven by cortisol, glucagon, and growth hormone—behaves differently in patients with insulin resistance. For those not on any therapy, fasting glucose can spike 20-50 mg/dL between 4-8 a.m., often pushing morning readings above 130 mg/dL. This becomes problematic when baseline insulin resistance keeps the liver pouring out excess glucose unchecked.

When patients begin low-dose tirzepatide or semaglutide, the GLP-1/GIP mechanisms powerfully suppress this hepatic glucose output. In our protocol, we target a much tighter range. A normal dawn phenomenon value for someone with insulin resistance on properly cycled tirzepatide is a fasting glucose rise of less than 10-15 mg/dL overnight, with morning fasting blood sugar consistently between 85-105 mg/dL. Anything above a 20 mg/dL rise signals residual inflammation, lectin exposure, or incomplete metabolic reset.

Protocol-Specific Targets from The 30-Week Tirzepatide Reset

Our book outlines three 70-day cycles that integrate low-dose tirzepatide cycling with a strict lectin-free low-carb diet, targeted Drops, red light therapy, and Japanese-style walking. During weeks 1-10, we expect dawn phenomenon suppression to improve weekly. By week 12 most patients see fasting glucose stabilize at 90-99 mg/dL with less than a 10 mg/dL overnight rise. This is measured via continuous glucose monitors or fasting labs at 3 a.m. and 7 a.m.

We never chase zero rise—that is unrealistic and can indicate hypoglycemia risk. Instead, we aim for physiologic stability. Patients who follow the 69 Transformation Steps, eliminate grains and lectins, and use our Brown Detox Drops typically achieve these numbers without escalating tirzepatide doses. Higher doses often mask the problem rather than fix the underlying hypothalamic and liver signaling.

Why These Numbers Matter for Long-Term Success

Chasing quick fixes with high-dose GLP-1s alone is one of the two biggest mistakes I see. Without rebuilding metabolic health, the dawn phenomenon returns stronger after stopping the medication, driving rebound weight gain. Our approach restores natural hormonal balance so the body self-regulates. John, a 60-year-old with Type 2 diabetes, entered our program with A1C 7.8 and dawn spikes of 45 mg/dL. After 10 weeks of the lectin-free protocol, cycling one box of tirzepatide exactly as prescribed, daily red light sessions, and walking intervals, his dawn rise dropped to 8 mg/dL and A1C fell to 6.2. By week 30 he was medication-free for diabetes and has maintained his 40-pound loss for over a year using chaotic intermittent fasting.

Non-scale victories matter more than the scale: better energy at 6 a.m., reduced joint pain, improved blood pressure, and clothing that fits differently. These indicate true metabolic freedom—the core teaching of The 30-Week Tirzepatide Reset.

Actionable Steps to Normalize Your Dawn Phenomenon

Start with a baseline CGM reading at 3 a.m. and 7 a.m. for seven days. Remove all grains, nightshades, and ultra-processed carbs. Begin low-dose tirzepatide cycling per the book’s exact schedule while adding Blue Hunger Drops and Brown Detox Drops. Incorporate 20-minute Japanese-style walking intervals before breakfast and 15 minutes of red light exposure daily. Track body composition weekly, not just weight. If your dawn rise stays above 15 mg/dL after four weeks, increase lectin-free vegetable volume and reassess sleep and stress. Most patients hit our target range by week 8 and maintain it long after the last injection because they have reset their metabolism rather than depending on medication.